Major trial aims to slow Parkinson's with smart drug testing
NCT ID NCT07207057
First seen Nov 01, 2025 · Last updated May 03, 2026 · Updated 21 times
Summary
This large clinical trial is testing several potential treatments at once to see if they can slow the progression of Parkinson's disease. About 1,200 people with Parkinson's will take either an experimental drug or a placebo for up to 36 months. The study uses a flexible design that allows promising treatments to continue and weak ones to be dropped, making the process faster and more efficient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSONS DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Ageing Research Unit
RECRUITINGNewcastle, NE4 5PL, United Kingdom
-
UCLH
RECRUITINGLondon, NW1 2PG, United Kingdom
Conditions
Explore the condition pages connected to this study.